BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Nusano Presenting at Industry Events in October

  October 7, 2024

   · 

  1 min read
• Press Releases

  Ultragenyx Receives Breakthrough Therapy Designation for Setrusumab (UX143) in Osteogenesis Imperfecta

  October 7, 2024

   · 

  6 min read
• Press Releases

  Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

  October 7, 2024

   · 

  6 min read
• Press Releases

  Nuvectis Pharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

  October 7, 2024

   · 

  1 min read
• Press Releases

  Insignis Therapeutics Announces Positive Results from Phase 1 Clinical Study of IN-001 Liquid Epinephrine Sublingual Spray for Anaphylaxis

  October 7, 2024

   · 

  5 min read
• Drug Development

  Halia Therapeutics Announces First Healthy Volunteer Dosed with HT-4253, a Novel Oral LRRK2 Inhibitor Targeting Neuroinflammation in Alzheimer’s Disease

  October 7, 2024

   · 

  3 min read
• News

  Cognito Therapeutics to Present New Data for Spectris™ in Alzheimer’s Disease at CTAD 2024

  October 7, 2024

   · 

  3 min read
• Press Releases

  InterVene, Inc. Announces $13 Million Series A Financing to Advance Recana™ System Through US Market Clearance

  October 7, 2024

   · 

  3 min read
• News

  Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer

  October 7, 2024

   · 

  5 min read
• Business

  Inozyme Pharma Announces Appointment of Biopharmaceutical Commercial Leader Erik Harris to its Board of Directors

  October 7, 2024

   · 

  6 min read